| Literature DB >> 27492200 |
Dalila Nunes Cysne1, Thiare Silva Fortes1, Aramys Silva Reis1,2,3, Bruno de Paulo Ribeiro1, Amália Dos Santos Ferreira4, Flavia Maria Mendonça do Amaral5, Rosane Nassar Meireles Guerra1, Claudio Romero Farias Marinho2, Roberto Nicolete4,6, Flávia Raquel Fernandes Nascimento7.
Abstract
In an effort to identify novel therapeutic alternatives for the treatment of malaria, the present study evaluated the antimalarial effect of the crude hydroalcoholic extract (HCE) from the leaves of Chenopodium ambrosioides L. For this purpose, the molecular affinity between the total proteins from erythrocytes infected with Plasmodium falciparum and HCE or chloroquine was evaluated by surface plasmon resonance (SPR). Subsequently, the plasmodicidal potential of HCE was assessed in a P. falciparum culture. Using BALB/c mice infected with Plasmodium berghei intraperitoneally (ip.), we evaluated the effects of ip. treatment, for three consecutive days (day 7, 8, and 9 after infection), with chloroquine (45 mg/kg) or HCE (5 mg/kg), considering the survival index and the parasitaemia. The groups were compared to an untreated control group that receives only PBS at the same periods. The results indicated that HCE could bind to the total proteins of infected erythrocytes and could inhibit the parasite growth in vitro (IC50 = 25.4 g/mL). The in vivo therapeutic treatment with HCE increased the survival and decreased the parasitaemia in the infected animals. Therefore, the HCE treatment exhibited a significant antiplasmodial effect and may be considered as a potential candidate for the development of new antimalarial drugs.Entities:
Keywords: Chenopodium ambrosioides; Malaria; Plasmodium; Treatment
Mesh:
Substances:
Year: 2016 PMID: 27492200 DOI: 10.1007/s00436-016-5216-x
Source DB: PubMed Journal: Parasitol Res ISSN: 0932-0113 Impact factor: 2.289